Herpes zoster in an immunocompetent young patient following mRNA-1273 vaccine for COVID-19: A case report

Main Article Content

Nanjiba Nawaz
Penn State College of Medicine

Christen Samaan
Penn State Hershey Department of Dermatology

Alexandra Flamm
Penn State Hershey Department of Dermatology

Keywords

Herpes Zoster, Moderna vaccine, Immunocompetent

References

1. Bostan E, Yalici‐Armagan B. Herpes zoster following inactivated COVID‐19 vaccine: A coexistence or coincidence? Journal of Cosmetic Dermatology. 2021;20(6):1566-1567. PMID: 33638924.

2. Tartari F, Spadotto A, Zengarini C, Zanoni R, Guglielmo A, Adorno A, Valzania C, Pileri A. Herpes zoster in COVID‐19‐positive patients. International Journal of Dermatology. 2020; 59(8):1028-1029. PMID: 32530063

3. Lee C, Cotter D, Basa J, Greenberg HL. 20 Post COVID‐19 Vaccine Related Shingles Cases seen at the Las Vegas Dermatology Clinic and sent to us via Social Media. Journal of Cosmetic Dermatology. 2021;20(7):1960-1964. PMID: 33991162

4. McMahon DE, Amerson E, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, Desai SR, French LE, Lim HW, Thiers BH, Hruza GJ. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. Journal of the American Academy of Dermatology. 2021;85(1):46-55. PMID: 33838206

5. Rodríguez-Jiménez P, Chicharro P, Cabrera LM, Seguí M, Morales-Caballero Á, Llamas-Velasco M, Sánchez-Pérez J. Varicella-Zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: report of 5 cases. JAAD Case Reports. 2021; 12:58-9. PMID: 33937467

6. Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M. Herpes zoster co-infection in an immunocompetent patient with COVID-19. Cureus. 2020;12(7) :e8998. PMID: 32670724

Article Sidebar

PDF
Published
Jan 17, 2022
DOI https://doi.org/10.25251/skin.6.1.16

Article Details

How to Cite
Nawaz, N., Samaan, C., & Flamm, A. (2022). Herpes zoster in an immunocompetent young patient following mRNA-1273 vaccine for COVID-19: A case report. SKIN The Journal of Cutaneous Medicine, 6(1), 76–78. https://doi.org/10.25251/skin.6.1.16
Issue
Vol. 6 No. 1 (2022)
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.